TBI is common, and healing requires reducing inflammation, restoring mitochondria, and boosting neuroplasticity. Low‑dose ...
The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results